5-Carboxymethylaminomethyluridine (cmnm(5)U) and 5-carboxymethylaminomethyl-2-thiouridine (cmnm(5)s(2)U) are located at the wobble position in several cytosolic and mitochondrial tRNA sequences. In this paper, we report the first site-selected incorporation of cmnm(5)U and cmnm(5)s(2)U into RNA sequences by phosphoramidite chemistry on a CPG solid support. Trifluoroacetyl and 2-(trimethylsilyl)ethyl were selected for the protection of the amine and carboxyl functions, respectively.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c3ob42302f | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial.
JAMA Cardiol
October 2023
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Article Synopsis
- A recent clinical trial tested a new coronary computed tomography angiography (cCTA) strategy, aimed at improving efficiency for patients with stable chest pain compared to traditional stress testing methods.
- The trial, involving over 2000 participants from North America and Europe, assigned patients to either a precision strategy (PS) using risk assessment for testing decisions or usual testing (UT), which included stress tests.
- Results showed that the PS group had significantly lower rates of unnecessary catheterizations and better efficiency outcomes than the UT group, indicating that the new approach could enhance patient care.
Site-selected incorporation of 5-carboxymethylaminomethyl(-2-thio)uridine into RNA sequences by phosphoramidite chemistry.
Org Biomol Chem
February 2014
Institute of Organic Chemistry, Zeromskiego St. 116, Lodz, Poland.
5-Carboxymethylaminomethyluridine (cmnm(5)U) and 5-carboxymethylaminomethyl-2-thiouridine (cmnm(5)s(2)U) are located at the wobble position in several cytosolic and mitochondrial tRNA sequences. In this paper, we report the first site-selected incorporation of cmnm(5)U and cmnm(5)s(2)U into RNA sequences by phosphoramidite chemistry on a CPG solid support. Trifluoroacetyl and 2-(trimethylsilyl)ethyl were selected for the protection of the amine and carboxyl functions, respectively.
View Article and Find Full Text PDFBone mass and density response to a 12-month trial of calcium and vitamin D supplement in preadolescent girls.
J Musculoskelet Neuronal Interact
March 2003
Center for Pediatric Nutrition Research, Department of Pediatrics, University of Utah, Salt Lake City, UT 84132, USA.
Background: Maximal bone acquisition in adolescent girls through dietary and lifestyle practices is advocated to prevent or minimize the development of osteoporosis and its associated complications in later life. Longitudinal investigations of bone acquisition in children and adolescents have utilized areal bone mineral density (BMD, mg/cm(2)) as a measure of bone mass and strength. Peripheral quantitative computed tomography (pQCT), which provides a three-dimensional display of data, separate analyses of bone compartments, and bone mass in terms of volumetric BMD (vBMD, mg/cm(3)), has recently been introduced for clinical use.
View Article and Find Full Text PDFSite-selected introduction of modified purine and pyrimidine ribonucleosides into RNA by automated phosphoramidite chemistry.
Biochimie
August 1995
Department of Biochemistry, North Carolina State University, Raleigh 27695-7622, USA.
The study of modified nucleoside contributions to RNA chemistry, structure and function has been thwarted by the lack of a site-selected method of incorporation which is both versatile and adaptable to present synthetic technologies. A reproducible and versatile site-selected incorporation of nine differently modified nucleosides into hepta- and octadecamer RNAs has been achieved with automated phosphoramidite chemistry. The 5'-O-(4,4'-dimethoxytrityl-2'-O-tert-butyldimethylsilyl-ribonucleoside- 3'-O-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite syntheses of m5C, D, psi, riboT, s2U, mnm5U, m1G and m2A were designed for compatibility with the commercially available major and 2'OH methylated ribonucleoside phosphoramidites.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!